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CARDIOVASCULAR MEDICINE
Comparison of monophasic and biphasic shocks for
transthoracic cardioversion of atrial fibrillation
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Objective: To compare the efficacy of cardioversion in patients with atrial fibrillation between
monophasic damped sine waveform and rectilinear biphasic waveform shocks at a high initial energy
level and with a conventional paddle position.
Design: Prospective randomised study.
Patients and setting: 227 patients admitted for cardioversion of atrial fibrillation to a tertiary referral
centre.
Results: 70% of 109 patients treated with an initial 200 J monophasic shock were cardioverted to
sinus rhythm, compared with 80% of 118 patients treated with an initial 120 J biphasic shock (NS).
After the second shock (360 J monophasic or 200 J biphasic), 90% of the patients were in sinus rhythm
in both groups. The mean cumulative energy used for successful cardioversion was 306 J for monopha-
sic shocks and 159 J for biphasic shocks (p < 0.001).
Conclusions: A protocol using monophasic waveform shocks in a 200–360 J sequence has the same
efficacy (90%) as a protocol using rectilinear biphasic waveform shocks in a 120–200 J sequence. This
equal efficacy is achieved with a significantly lower mean delivered energy level using the rectilinear
biphasic shock waveform. The potential advantage of lower energy delivery for cardioversion of atrial
fibrillation needs further study.
External electrical cardioversion remains the technique ofchoice for restoring sinus rhythm in patients withpersistent atrial fibrillation.1 Most currently used exter-
nal defibrillators deliver monophasic damped sine waveform
shocks. However, it has been shown that a comparable or even
higher rate of transthoracic cardioversion can be achieved
with biphasic shocks.2 3 These studies assessed efficacy using
step up protocols starting at low energy levels. However, 75%
of the patients can be cardioverted successfully by the
currently recommended 200 J initial energy level4 using
monophasic shock waveforms. Our aim in this prospective
randomised study was thus to compare the efficacy of
monophasic and biphasic waveform shocks for cardioversion
of patients with atrial fibrillation at this initial energy level,
using a conventional paddle position.
METHODS
Patient population
Two hundred and twenty seven consecutive patients were
enrolled in this prospective randomised single centre study
between August 2000 and January 2002. Criteria for inclusion
were as follows: atrial fibrillation lasting more than 24 hours;
a minimum period of medical treatment of three weeks with
acenocoumarol or fenprocoumon, with an international
normalised ratio (INR) of > 2.5; and absence of an
intracardiac thrombus on a transoesophageal echocardiogram
done within 24 hours of the cardioversion. Transthoracic
echocardiograms were done in all patients within 30 days of
the cardioversion in order to measure left atrial dimensions.
Patients with untreated hyperthyroidism and pregnant
women were excluded from the study. Patients who were car-
dioverted for arrhythmias other than atrial fibrillation
(including atrial flutter) were not included in the analysis.
Sixteen patients undergoing cardioversion for atrial fibrilla-
tion in the study period were excluded because of violation of
the study protocol by the treating physician.
Protocol for cardioversion
Cardioversions were done under deep sedation using weight
adjusted intravenous diazepam and ethomidate in the postab-
sorptive state. Randomisation was achieved on the basis of the
Table 1 Clinical characteristics of the patients
Monophasic Biphasic p Value
Number 109 118
Female (%) 24.8 25.4 NS
Age (years) 59.9 (14.0) 59.6(12.4) NS
Height (cm) 176.4 (10.0) 177.9 (10.7) NS
Weight (kg) 82.5 (19.8) 81.9 (20.8) NS
Body mass index (kg/m2) 26.5 (5.2) 26.5 (5.7) NS
LA diameter (mm) 46.3 (8.4) 44.4 (8.9) NS
Mean impedance (ohm) 68.5 (18.5) 80.1 (19.7) NS
Impedance measured (n (%)) 45 (41) 70 (59) NS
Duration AF (days) (median (range)) 41.0 (1–450) 20.5 (1–390) NS
Duration AF unknown (n) 70 72 NS
Values are mean (SD) unless stated.
AF, atrial fibrillation; LA, left atrial.
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patient’s birthday. Patients born on an uneven day received a
200–360 J monophasic shock sequence; patients born on an
even day received a 120–200 J biphasic shock sequence.
Shocks were delivered by commercially available defibrillators.
The monophasic damped sine wave shock was delivered by a
Hewlett Packard M1722B defibrillator (Hewlett Packard Co,
Andover, Massachusetts, USA) and the rectilinear biphasic
waveform by a Zoll M series biphasic defibrillator (Zoll Medi-
cal Corporation, Burlington, Massachusetts, USA). Cardiover-
sions were undertaken using an anterolateral paddle position,
and were considered successful if sinus rhythm was restored
for more than five seconds. Measurement of the shock imped-
ance was given by the defibrillator.
Statistical analysis
Variables were expressed as mean (SD) or median (range) as
required. Student’s t test was used to compare continuous
variables. A χ2 test was done for comparison of non-
dichotomous variables. A probability value of p < 0.05 was
considered significant.
RESULTS
In the study period, 359 patients were cardioverted in our
department. One hundred and thirty two were excluded from
the analysis either because the cardioversion was done for
atrial flutter or atrial tachycardia (n = 116), or because of vio-
lation of the protocol (n = 16). Using the above mentioned
selection criteria, 227 patients were enrolled into the final
analysis.
The clinical characteristics of the 227 patients who fulfilled
the criteria for inclusion are listed in tables 1 and 2. The
monophasic and biphasic groups were similar in age, sex dis-
tribution, body weight, height, body mass index, left atrial
diameter, and antiarrhythmic drug treatment. The measured
shock impedance showed no difference between the two
groups. Shock impedance values were not available in all
patients. Information about the duration of the atrial fibrilla-
tion was also not always available. In about half the patients
where data were available, there was no significant difference
in shock impedance and atrial fibrillation duration between
the two groups.
Monophasic and biphasic shock efficacy
The comparisons of monophasic and biphasic shock efficacy
are shown in fig 1. The first shock (200 J) was successful in 77
of 109 patients (71%) in the monophasic waveform group, and
in 95 of 118 patients (81%) in the biphasic waveform group.
This difference was not significant (p = 0.08). The cumulative
success of two shocks was 106 of 118 patients (91%) for the
biphasic waveform group (120 J and 200 J) and 98 of 109
patients (90%) for the monophasic waveform group (200 J
and 360 J). Similar efficacy was achieved with a significantly
lower mean delivered energy level (p < 0.001) using the
biphasic shock waveform (159 J) compared with the
monophasic shock waveform (306 J). There were no compli-
cations related to the method of anaesthesia used. In seven
patients treated with the biphasic protocol there was early
recurrence of atrial fibrillation within five seconds after the
first (120 J) or second (200 J) shock. In the monophasic group
early recurrence of atrial fibrillation occurred in three patients.
These were all considered unsuccessful results. In one patient
successfully treated with the biphasic protocol, recurrence of
Table 2 Drug treatment and underlying diseases in
the patients
Monophasic Biphasic
Drug treatment
Digoxin 29 (27%) 13 (11%) NS
Class Ic AAD 8 (7%) 13 (11%) NS
β Blocker 18 (16%) 14 (12%) NS
Class III AAD* 56 (51%) 75 (63%) NS
Underlying diseases
Valvar disease 19 (17%) 15 (13%) NS
Lone AF 15 (14%) 25 (21%) NS
Congestive HF 12 (11%) 11 (9%) NS
Hypertension 12 (11%) 9 (7%) NS
CAD 6 (6%) 5 (4%) NS
*Sotalol or amiodarone.
AAD, antiarrhythmic drug; AF, atrial fibrillation; CAD, coronary
artery disease; HF, heart failure.
Figure 1 Study protocol and data
on shock efficacy (%).
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atrial fibrillation was noted after five seconds but within five
minutes. This was considered as successful treatment.
DISCUSSION
In this study we could not confirm that cardioversion efficacy
improves when biphasic shocks are used. The major finding of
the study was that identical success rates can be achieved with
monophasic and biphasic shock waveforms, selecting an
initial energy level of 200 J and 120 J, respectively. As efficacy
was similar with a lower delivered energy using biphasic shock
waveforms, it seems necessary to investigate the potential
clinical value of low energy cardioversion for patients with
persistent atrial fibrillation.
Clinical value of the shock waveform
Biphasic shocks are more effective for endocardial defibrilla-
tion than monophasic shocks.5 6 For transthoracic ventricular
defibrillation, biphasic and monophasic shocks are equally
effective, but biphasic shocks require less energy for the same
efficacy.7 A similar superiority for external cardioversion of
atrial fibrillation has been reported recently by Mittal and col-
leagues using rectilinear biphasic waveform shocks.2 Ricard
and colleagues showed that for the same energy levels
truncated exponential biphasic waveform shocks are superior
in efficacy to monophasic waveform shocks.3 For defibrillation
of ventricular fibrillation it was found that the ST segment 10
seconds after the shock was less impaired by biphasic
waveform shocks than by monophasic waveform shocks in a
study that included 297 patients.7
Biphasic waveform defibrillation produced less impairment
of cardiac function as measured by echocardiography, arterial
pressure, and recurrence of heart rate in a study using
mechanically ventilated pigs.8 However, biochemical studies
did not suggest any myocardial damage after cardioversion for
atrial fibrillation.3 9 10
Selection of the initial energy level
Based on a study by Joglar and colleagues,11 it has been
recommended12 that a 100 J monophasic shock should not be
used as the initial energy level for cardioversion of atrial fibril-
lation because of the relatively low success rate. Current
recommendations13 14 suggest using higher initial energy levels
because the success rate only becomes satisfactory at an
energy level of 200 J or more (for monophasic waveforms),
with a consequent decrease in cumulative delivered energy.
According to the results of former studies with biphasic
cardioversions, we hypothesised that a biphasic shock of 120 J
may be as effective as a monophasic shock of 200 J.3 4 Indeed
this study did not show any difference in first shock efficacy
and cumulative efficacy between two step protocols using
monophasic (200 J and 360 J) and biphasic (120 J and 200 J)
shock waveform sequences for cardioversion. The advantages
of low energy cardioversion are not yet proven, but it could
have an important clinical impact. Furthermore we achieved a
remarkable 90% overall success rate using biphasic low energy
cardioversion. This may influence further strategic planning
as it could reduce the need for internal cardioversion, an
effective but invasive form of treatment.
Limitations of the study
Because different defibrillators were used, the study was not
double blind. The number of patients was limited but
relatively large compared with previous reports. Data were not
complete regarding the duration of the current atrial fibrilla-
tion episode, a known predictor of successful cardioversion.
Although we clearly demonstrated that equal efficacy could be
achieved with less delivered energy using biphasic shock
waves, we did not attempt to assess its effect on atrial
function, including differences in the development of atrial
stunning.
Conclusions
For electrical cardioversion of atrial fibrillation, a protocol
using biphasic waveform shocks in a 120–200 J sequence has
the same efficacy as a protocol using monophasic waveform
shocks in a 200–360 J sequence. This equal efficacy is achieved
with a significantly lower mean delivered energy level in the
rectilinear biphasic shock waveform. The potential advantages
of a lower energy requirement for cardioversion of atrial fibril-
lation require further study in patients with persistent atrial
fibrillation. However, as myocardial damage after cardiover-
sion for atrial fibrillation has not so far been reported, there is
no need for the immediate replacement of all defibrillators
delivering monophasic waveform shocks.
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